Genetic engineering concept. Medical science. Scientific Laboratory.
image-

LineaRx Achieves Anti-CD19 Expression in Human CAR T Cells via Plasmid-Free Platform

Posted on

STONY BROOK N.Y., April 8, 2019 – Applied DNA Sciences, Inc. (NASDAQ: APDN) announced today that LineaRx, (the “Company”), its subsidiary focused on next-generation biotherapeutics, has achieved anti-CD-19 CAR (Chimeric Antigen Receptor) expression in human T Cells via its proprietary, non-viral, plasmid-free (NVPF) manufacturing platform. To the Company’s knowledge, this seminal event represents the first […]

Read More email